関連する実験動画
Updated: Jun 24, 2026
09:40
Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
核サイトカインで活性化されたIKKalphaは,マスピン抑制によって前立腺がんの転移を制御します
Jun-Li Luo1, Wei Tan, Jill M Ricono
1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Cancer Center, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0723, USA.
Nature
|March 23, 2007
まとめ
炎症は,マスピン転移抑制剤を抑制するIkappaBキナーゼアルファ (IKKalpha) を活性化することによって,前立腺がんの転移を促進します. この経路は,炎症細胞と前立腺がんの進行と転移を結びつける.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- 炎症は,NF-kappaB経路を通じて腫瘍の成長を促進することが知られている.
- NF-kappaBのシグナル伝達は,上皮質-メゼンキマの移行と転移に関与しています.
- 炎症と癌の転移の間の直接的なメカニズム的な関連は,未だに曖昧である.
研究 の 目的:
- 前立腺がんの進行および転移におけるIkappaBキナーゼアルファ (IKKalpha) の役割を調査する.
- 炎症が前立腺がんの転移に影響を与える分子機構を解明する.
主な方法:
- 前立腺がんのTRAMPマウスモデルを使用した.
- IKKalpha活性化の役割と,マスピン発現に対するその下流効果を調査した.
- マウスとヒトの前立腺がんのサンプルにおける転移性進行と相関する核IKKalphaレベル.
主要な成果:
- IKKalpha活性化の阻害は,TRAMPマウスにおける前立腺がんの成長と転移を著しく減少させた.
- 転移の減少はマスピン発現の増加と相関しており,マスピン切除により転移の可能性が回復した.
- RANKLで活性化されたIKKalphaは,マスピン発現を抑制し,活性IKKalphaの核転位を必要とします.
結論:
- 腫瘍に浸透するRANKL発現性炎症細胞によって引き起こされる核IKKalpha活性化は,Maspin転写を阻害する.
- この経路は,Maspinを抑制することによって前立腺がんの転移を促進します.
- RANKL-IKKalpha-Maspin軸をターゲットにすることで,前立腺がんの転移に対する治療戦略を提供することができる.
関連する概念動画
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...